Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
Andrea Vallés‐Martí(Amsterdam Neuroscience), Maarten F. Bijlsma(Dutch Cancer Society)
Cited by 9
Related Papers
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597
Molecular subtyping of cancer: current status and moving toward clinical applications
|Briefings in Bioinformatics|2018|150
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
|EMBO Reports|2020|39
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma
|Cell Reports|2023|26
Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma
|Pharmacological Research|2024|4